Nagaraja, P. A.; Mathew, T.; Shetty, D. P.
April 2005
Indian Journal of Medical Microbiology;Apr2005, Vol. 23 Issue 2, p139
Academic Journal
The incidence of endocarditis produced by the so-called "opportunists" as a complication of prosthetic valve surgery is progressively increasing in frequency and gradually transforming the clinical picture habitually associated with this disease. Candida endocarditis is an unusual but severe complication caused by Candida albicans or other fungal species. This case and a review of the literature indicate that Candida endocarditis treated with amphotericin B and prosthetic valve replacement may recur months after treatment, and that late recurrent Candida endocarditis, which is difficult to diagnose and treat, may be best prevented by lifelong antifungal suppressive therapy.


Related Articles

  • Worsening of Endogenous Candida albicans Endophthalmitis During Therapy with Intravenous Lipid... Virata, Steven R.; Kylstra, Jan A.; Brown, Justin C.; Wohl, David A.; Cohen, Myron S. // Clinical Infectious Diseases;5/1/1999, Vol. 28 Issue 5, p1177 

    Describes a patient with endogenous Candida albicans endophthalmitis that progressed after intravenous antifungal therapy was changed from fluconazole to lipid complex amphotericin B. Clinical diagnosis; Medical treatment; Efficacy of intravenous amphotericin B in treating C. albicans...

  • In vitro activity of antifungal combinations against Candida albicans biofilms. Tobudic, Selma; Kratzer, Christina; Lassnigg, Andrea; Graninger, Wolfgang; Presterl, Elisabeth // Journal of Antimicrobial Chemotherapy (JAC);Feb2010, Vol. 65 Issue 2, p271 

    Objectives: The aim of the present study was to evaluate the in vitro activity and synergism of the combinations of amphotericin B/caspofungin and amphotericin B/posaconazole against Candida albicans, grown either as planktonic cells or in biofilms.

  • Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans. Mahmoudabadi, Ali Zarei; Zarrin, Majid; Kiasat, Neda // Jundishapur Journal of Microbiology;Jul2014, Vol. 7 Issue 7, p1 

    Background: The ability of Candida albicans to form biofilms and adhere to host tissues and biomaterial surfaces is an important factor in its pathogenesis. One of the main characteristics of biofilms is their resistance to broad-spectrum anti-microbial drugs. Objectives: In the present study...

  • Epsilometer Test-Based Determination of Susceptibility of Clinically Important Candida Isolates to Conventional Antifungal Agents. Abu-Elteen, Khaled H.; Hamad, Mawieh A.; Kavanagh, Kevin // Journal of Medical Sciences;2007, Vol. 7 Issue 3, p374 

    One hundred thirty yeast clinical isolates comprised of 81 C. albicans, 22 C. tropicalis, 11 C. parapsilosis, 9 C. glabrata and 7 C. krusei were evaluated for antifungal susceptibility using the E-test. MIC, MIC50 and MIC90 of amphotericin B (AMB), flucytosine (FC), fluconazole (FL),...

  • In Vitro Effect of Amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis Biofilm Formation. Prażyńska, Małgorzata; Gospodarek, Eugenia // Mycopathologia;Feb2014, Vol. 177 Issue 1/2, p19 

    Candida spp. biofilm is considered highly resistant to conventional antifungals. The aim of this study was to investigate the in vitro effect of amphotericin B on Candida spp. biofilms at different stages of maturation. We investigated the activity of amphotericin B against 78 clinical isolates...

  • Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro. Vieira, Débora B.; Carmona-Ribeiro, Ana M. // Journal of Nanobiotechnology;2008, Vol. 6, Special section p1 

    Background: Particulate systems are well known to be able to deliver drugs with high efficiency and fewer adverse side effects, possibly by endocytosis of the drug carriers. On the other hand, cationic compounds and assemblies exhibit a general antimicrobial action. In this work, cationic...

  • Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. Delattin, Nicolas; De Brucker, Katrijn; Vandamme, Katleen; Meert, Els; Marchand, Arnaud; Chaltin, Patrick; Cammue, Bruno P. A.; Thevissen, Karin // Journal of Antimicrobial Chemotherapy (JAC);Apr2014, Vol. 69 Issue 4, p1035 

    Objectives Biofilms of Candida species, often formed on medical devices, are generally resistant to currently available antifungal drugs. The aim of this study was to identify compounds that increase the activity of amphotericin B and caspofungin, commonly used antifungal agents, against Candida...

  • Evaluation of Antifungal Susceptibility Testing with Microdilution and Etest Methods of Candida Blood Isolates. Metin, Dilek Yesim; Hilmioglu-Polat, Suleyha; Samlioglu, Pinar; Doganay-Oflazoglu, Biray; Inci, Ramazan; Tumbay, Emel // Mycopathologia;Sep2011, Vol. 172 Issue 3, p187 

    Candida species that show an increasing number of clinical and/or microbiological resistance to several antifungals and are the most common agents of invasive fungal infections. The aim of this study was to investigate the in vitro susceptibility of Candida blood isolates to antifungal agents...

  • Flow cytometry susceptibility testing for conventional antifungal drugs and Comparison with the NCCLS Broth Macrodilution Test. J., Najafzadeh M.; M., Falahati; K., Pooshanga Bagheri; A., Fata; R., Fateh // DARU;2009, Vol. 17 Issue 2, p94 

    Introduction: During the last decade, the incidence of fungal infection has been increased in many countries. Because of the advent of resistant to antifungal agents, determination of an efficient strategic plan for treatment of fungal disease is an important issue in clinical mycology. Many...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics